ACCU Revenue and Competitors
Estimated Revenue & Valuation
- ACCU's estimated annual revenue is currently $11.6M per year.
- ACCU's estimated revenue per employee is $145,000
Employee Data
- ACCU has 80 Employees.
- ACCU grew their employee count by 14% last year.
ACCU's People
| Name | Title | Email/Phone |
|---|
ACCU Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $60M | 331 | 24% | N/A | N/A |
#2 | $5.3M | 46 | -6% | N/A | N/A |
#3 | $36.8M | 236 | -3% | $46.9M | N/A |
#4 | $15.1M | 104 | 4% | N/A | N/A |
#5 | $1.4M | 16 | -6% | N/A | N/A |
#6 | $1.4M | 16 | -6% | N/A | N/A |
#7 | $3.5M | 30 | -12% | N/A | N/A |
#8 | $146M | 719 | 6% | N/A | N/A |
#9 | $99.7M | 550 | -1% | N/A | N/A |
#10 | $12.9M | 89 | -3% | $3.5M | N/A |
What Is ACCU?
Association of programmers devoted to professionalism in programming. As a member of the ACCU you are part of a community of programmers who care about programming. The ACCU is a tremendous forum for interacting and meeting with programmers through the discussions, the articles in the ACCU journals, online study groups and the ACCU conference.
keywords:N/A
N/A
Total Funding
80
Number of Employees
$11.6M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ACCU News
(Novartis), Topcon Corporation, Accu-Scope Inc., Alltion Co. Ltd., Carl Zeiss Meditec AG, ARI Medical Technology Co. Ltd., Takagi Seiko Co. Ltd.
Abbott, Accu-Chek, Animas, Bayer, Bristol-Myers Squibb, DexCom, Eli Lilly, Insulet Corp, Johnson & Johnson, LifeScan, Medtronic, Merck, Microport, Novartis,...
Accu-Precision has 30 machines at their machine shop in Littleton, and they have a bin underneath each of them that gets filled up with scrap,...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.6M | 80 | -19% | N/A |
#2 | $21.6M | 80 | 7% | N/A |
#3 | $26M | 80 | 5% | N/A |
#4 | $12M | 80 | -6% | N/A |
#5 | $21.6M | 80 | 13% | N/A |